Join
Live feed
·
INSIDERFilingvia Quantisnow
REGENXBIO Inc. logo

Chief Medical Officer Pakola Steve sold $168,705 worth of shares (15,309 units at $11.02) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 232,617 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RGNX· REGENXBIO Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RGNX (REGENXBIO Inc.) and more on Quantisnow.